These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 25645984)
1. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma. Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984 [TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823 [TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
4. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367 [TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas. Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985 [TBL] [Abstract][Full Text] [Related]
6. Snail and slug play distinct roles during breast carcinoma progression. Côme C; Magnino F; Bibeau F; De Santa Barbara P; Becker KF; Theillet C; Savagner P Clin Cancer Res; 2006 Sep; 12(18):5395-402. PubMed ID: 17000672 [TBL] [Abstract][Full Text] [Related]
7. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis. Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer. Wan G; Tian L; Yu Y; Li F; Wang X; Li C; Deng S; Yu X; Cai X; Zuo Z; Cao F Biochem Biophys Res Commun; 2017 Sep; 491(1):104-111. PubMed ID: 28709865 [TBL] [Abstract][Full Text] [Related]
9. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma. Kurioka K; Wato M; Iseki T; Tanaka A; Morita S Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335 [TBL] [Abstract][Full Text] [Related]
11. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related]
12. Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer. Yamashita N; Tokunaga E; Iimori M; Inoue Y; Tanaka K; Kitao H; Saeki H; Oki E; Maehara Y Clin Breast Cancer; 2018 Oct; 18(5):e1003-e1009. PubMed ID: 29526677 [TBL] [Abstract][Full Text] [Related]
13. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer. Fan XJ; Wan XB; Yang ZL; Fu XH; Huang Y; Chen DK; Song SX; Liu Q; Xiao HY; Wang L; Wang JP Hum Pathol; 2013 Feb; 44(2):173-80. PubMed ID: 22974478 [TBL] [Abstract][Full Text] [Related]
14. Expression of EMT Markers SLUG and TWIST in Breast Cancer. Grzegrzolka J; Biala M; Wojtyra P; Kobierzycki C; Olbromski M; Gomulkiewicz A; Piotrowska A; Rys J; Podhorska-Okolow M; Dziegiel P Anticancer Res; 2015 Jul; 35(7):3961-8. PubMed ID: 26124343 [TBL] [Abstract][Full Text] [Related]
15. Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer. Dubois-Marshall S; Thomas JS; Faratian D; Harrison DJ; Katz E Clin Exp Metastasis; 2011 Dec; 28(8):811-8. PubMed ID: 21789718 [TBL] [Abstract][Full Text] [Related]
16. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334 [TBL] [Abstract][Full Text] [Related]
17. ERalpha signaling through slug regulates E-cadherin and EMT. Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer. Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164 [TBL] [Abstract][Full Text] [Related]
19. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo. Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007 [TBL] [Abstract][Full Text] [Related]